A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Clinical trial NCT07456033 · RECRUITING
Trial details
- NCT number
- NCT07456033
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-13
- Primary completion
- 2030-09-23
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.